This report reviews operating characteristics and features of high-, medium-, and low-volume/POC clinical chemistry and immunodiagnostic systems.

The report also presents strategic assessments of current and emerging suppliers of clinical chemistry and immunodiagnostic products, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.